NCT01373125View on ClinicalTrials.gov

"Is the Neosquamous Epithelium Normal Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?"

CompletedOBSERVATIONAL
Enrollment

99

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Barrett's EsophagusIntestinal MetaplasiaGastroesophageal Reflux Disease (GERD)
Trial Locations (1)

27599

University of North Carolina Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

American Society for Gastrointestinal Endoscopy

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT01373125 - "Is the Neosquamous Epithelium Normal Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?" | Biotech Hunter | Biotech Hunter